Brief: Daxor Corporation Announces Partnership With Medaxiom To Further Adoption Of Daxor’s Blood Volume Diagnostic
21/07/2022 13:44
July 21 (Reuters) - Daxor Corp DXR.O :
* DAXOR CORPORATION ANNOUNCES PARTNERSHIP WITH MEDAXIOM TO
ADVANCE
AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME
DIAGNOSTIC (BVA-100®)
Source text for Eikon: ID:nGNX324qXt
Further company coverage: DXR.O
Recent news on Daxor
See all newsNASDAQ RESUMED AT 02:03 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:58 PM
Brief: Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology
Brief: Daxor Corporation Submits 510(K) To FDA For Next-Generation Blood Volume Analyzer
Brief: Daxor Corporation Streamlines Regulatory Strategy For Groundbreaking Diagnostic Device